CytoDyn (CYDY) Research & Development (2010 - 2024)
CytoDyn (CYDY) posted Research & Development of $3.6 million for Q2 2024, up 453.38% on a QoQ basis from $650000.0 in Q1 2024, and up 266.67% year-over-year from $981000.0 in Q2 2023.
CytoDyn (CYDY) Research & Development (2010 - 2024) Analysis & Trends
CytoDyn's Research & Development history runs 15 years deep, the most recent figure standing at $3.6 million for Q2 2024.
- Quarterly Research & Development rose 266.67% year-over-year to $3.6 million in Q2 2024, while the trailing twelve-month figure through May 2024 was $7.2 million (up 175.08% YoY) and the FY2024 annual result came in at $7.2 million, up 175.08% from the prior year.
- Research & Development was $3.6 million for Q2 2024 at CytoDyn, up from $650000.0 in the prior quarter.
- Across five years, Research & Development topped out at $19.9 million in Q2 2020 and bottomed at $137000.0 in Q4 2022.
- A 5-year average of $7.0 million and a median of $3.8 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development slumped 98.16% — and 2023, when it surged 687.59%.
- CytoDyn's Research & Development stood at $16.4 million in 2020, then plunged by 54.72% to $7.4 million in 2021, then slumped by 98.16% to $137000.0 in 2022, then jumped by 687.59% to $1.1 million in 2023, then surged by 233.36% to $3.6 million in 2024.
- Business Quant data shows CYDY's Research & Development at $3.6 million in Q2 2024, $650000.0 in Q1 2024, and $1.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | 3.60 Mn |
| Feb 29, 2024 | 650,000.00 |
| Nov 30, 2023 | 1.08 Mn |
| Aug 31, 2023 | 1.91 Mn |
| May 31, 2023 | 981,000.00 |
| Feb 28, 2023 | 938,000.00 |
| Nov 30, 2022 | 137,000.00 |
| Aug 31, 2022 | 576,000.00 |
| May 31, 2022 | 4.01 Mn |
| Feb 28, 2022 | 3.57 Mn |
| Nov 30, 2021 | 7.45 Mn |
| Aug 31, 2021 | 12.02 Mn |
| May 31, 2021 | 9.34 Mn |
| Feb 28, 2021 | 12.32 Mn |
| Nov 30, 2020 | 16.45 Mn |
| Aug 31, 2020 | 15.19 Mn |
| May 31, 2020 | 19.95 Mn |
| Feb 29, 2020 | 15.11 Mn |
| Nov 30, 2019 | 8.53 Mn |
| Aug 31, 2019 | 9.06 Mn |